Location History:
- Berkeley, CA (US) (2012)
- Oakland, CA (US) (2010 - 2017)
- Branford, CT (US) (2013 - 2017)
Company Filing History:
6 out of 6 
3 out of 9 
2 out of 3 Years Active: 2010-2017
Title: Innovations in Diabetes Prediction: The Contributions of Michael P. McKenna
Introduction: Michael P. McKenna, a prominent inventor based in Oakland, CA, has made significant contributions to the field of diabetes research through his innovative work. With a total of 12 patents to his name, his inventions focus on identifying biomarkers that help predict the risk of developing Type 2 diabetes, ultimately aiding in early diagnosis and intervention.
Latest Patents: McKenna's latest patents include groundbreaking inventions such as "Protein and lipid biomarkers providing consistent improvement to the prediction of Type 2 diabetes." This invention revolves around identifying specific biomarkers that are associated with diabetes, including protein and lipid metabolite biomarkers. It offers methods to use these biomarkers to gauge an individual's risk of developing diabetes and to screen populations for pre-diabetic conditions. Another notable patent is the "Method for determining risk of diabetes." This method includes measuring levels of various biomarkers from blood samples, which consist of glucose, adiponectin, CRP, IL2RA, ferritin, insulin, and HbA1c. It calculates a diabetes risk score to assist healthcare professionals in assessing patients.
Career Highlights: During his career, McKenna has worked with notable companies such as Tethys Bioscience, Inc. and True Health IP LLC. His work in these organizations has furthered the understanding of diabetes biomarkers and enhanced the methodologies used in risk assessment.
Collaborations: Throughout his illustrious career, McKenna has collaborated with esteemed professionals such as Michael S. Urdea and Patrick A. Arensdorf. Their collective expertise has been crucial in progressing research in diabetes prediction and creating innovative solutions for healthcare challenges.
Conclusion: Michael P. McKenna is a noteworthy inventor whose contributions to diabetes research have profound implications for early detection and prevention. His focus on biomarker development through his patented inventions demonstrates the critical interplay between innovation and healthcare, paving the way for advancements that can ultimately improve patient outcomes and health management strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.